文献速递前列腺癌

DaVinci 5与DaVinci Xi在机器人辅助根治性前列腺切除术中的围手术期结局比较

Perioperative outcomes comparing the DaVinci 5 with DaVinci Xi in patients undergoing robotic-assisted radical prostatectomy.
PubMed 文献 · Prostate Cancer Prostatic Dis · 2025-09-23

单中心回顾性队列研究比较DV5与DV-Xi行RARP的围手术期结局,DV5组103例,DV-Xi组101例。DV5组控制台时间和总手术时间中位数更短,但两组均无设备故障、术中并发症或输血,住院时间、术后并发症率及切缘状态无差异。

要点

  • DV5组控制台时间中位数缩短10分钟,总手术时间中位数缩短4分钟。
  • 两组均无设备故障、术中并发症或输血事件。
  • 住院时间、术后并发症率及手术切缘状态无显著差异。

核心结论

  • DV5机器人用于RARP与DV-Xi相比在部分围手术期指标上有小幅改善,但日常临床意义不显著。

研究设计与样本

  • 单中心回顾性队列研究,2024年4月至5月连续4周内DV5组103例与DV-Xi组101例行RARP。

主要发现

  • DV5组控制台时间中位数80分钟(IQR 80-90) vs DV-Xi组90分钟(IQR 80-90),中位差10分钟,p<0.001。
  • DV5组总手术时间中位数96分钟(IQR 90-103) vs DV-Xi组100分钟(IQR 98-105),中位差4分钟,p<0.001。
  • 两组均无设备故障、术中并发症或输血;住院时间、术后并发症率及手术切缘状态无差异。

临床怎么用

  • DV5平台在RARP中可小幅缩短控制台和总手术时间,但未改善短期临床结局,选择平台时可综合考虑。

局限性

  • 单中心高容量前列腺癌转诊中心研究,结果外推性可能受限。
  • 随访时间短,长期影响仍在评估中。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In the last two decades, several Da Vinci robotic platforms have been released. The new generation DaVinci-5 robot (DV5) promises hardware and software improvements with the potential for enhanced operative performance. The study aimed to compare the intraoperative performances and short-term perioperative outcomes between the DV5 and DaVinci-Xi robotic platforms in patients undergoing robotic-assisted radical prostatectomy (RARP). METHODS: We conducted a single-center retrospective cohort study from April to May 2024, during a unique 4-week period when both the Da Vinci 5 (DV5) and Da Vinci Xi (DV-Xi) platforms were available. A total of 103 patients who underwent robotic-assisted radical prostatectomy with the DV5 were retrospectively compared to 101 patients operated on with the DV-Xi during the same time frame. The primary endpoint was the comparison of intraoperative performance metrics between groups, including operative time, estimated blood loss, and intraoperative complications. RESULTS: The DV5 had shorter median console time (80 min, IQR [80-90] vs 90 min, IQR [80-90], median difference = 10 min, p < 0.001) and shorter median total operative time (96 min, IQR [90-103] vs 100 min, IQR [98-105], median difference = 4 min, p < 0.001). Neither group had any device malfunctions, intraoperative complications, or blood transfusions. We could not find the difference in hospital length-of-stay, postoperative complication rate, and surgical margin status. This study was done at a high-volume prostate cancer referral centre, which may limit the study findings' generalizability. CONCLUSION: This is the first study comparing outcomes of the DV5 and DVXi robotic platforms in patients undergoing RARP. The use of the DV5 robot was associated with modest gains in some perioperative outcomes, but these values were not clinically significant in our routine. Due to the short-term follow-up, we are still evaluating the long-term impacts of this new platform on these patient's outcomes.

来源:Prostate Cancer Prostatic Dis,查看原文。版权归原作者所有。

引用

  1. Reddy SK, Covas Moschovas M, Saikali S, et al. Perioperative outcomes comparing the DaVinci 5 with DaVinci Xi in patients undergoing robotic-assisted radical prostatectomy. Prostate Cancer Prostatic Dis. 2025. PMID: 40987853. doi:10.1038/s41391-025-01025-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。